Annual report [Section 13 and 15(d), not S-K Item 405]

Restatement of Quarterly Financial Information (Unaudited) - Condensed Consolidated Statements of Operations (Details)

v3.25.1
Restatement of Quarterly Financial Information (Unaudited) - Condensed Consolidated Statements of Operations (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Unaudited Condensed Consolidated Statements of Operations    
Revenue $ 110,451 $ 97,612
Cost of revenue 70,560 59,024
Gross profit 39,891 38,588
Research and development 29,188 27,650
General and administrative 49,744 41,999
Total operating expenses 108,625 97,368
Loss from operations (68,734) (58,780)
Other (expense) income, net (1,912) (2,272)
Total other income (expense), net (33,925) (18,920)
Loss before income taxes (102,659) (77,700)
Income tax provision (benefit) 159 (142)
Net loss $ (102,818) $ (77,558)
Basic net loss per share $ (4.26) $ (3.96)
Diluted net loss per share $ (4.26) $ (3.96)
Weighted-average shares used in computing basic net loss per share 24,159,770 19,580,006
Weighted-average shares used in computing diluted net loss per share 24,159,770 19,580,006
Prior Period Adjustment Restatement Of Condensed Consolidated Statements of Comprehensive Loss [Abstract]    
Net loss $ (102,818) $ (77,558)
Foreign currency translation adjustments (5,213) 2,318
Comprehensive loss (108,032) (75,206)
Prior Period Adjustment Restatement Of Condensed Consolidated Statements of Cash Flows [Abstract]    
Net Income (Loss) (102,818) (77,558)
Change in contract assets (3,119) 1,647
Other current assets 12,445 (9,803)
Change in contract liabilities 2,748 13,693
Net Cash used in operating activities (18,453) (36,307)
Purchase of property and equipment (26,581) (17,352)
Net cash used in investing activities (14,231) (4,968)
Effect of foreign currency translation on cash, cash equivalent and restricted cash $ 3,737 $ (568)